Therapeutical category:

Oral broad-spectrum cephalosporin

Characteristics:

A crystalline powder. No solvents are used in the process for higher purity with the exception of acetone used for the final product wash. Methanol is used for side chain activation.

Applications:

The product is suitable for the manufacture of powders and granules for oral suspensions and tablets, after the addition of appropriate excipients.

Regulatory information:

EU:EDQM

USA: FDA

Canada: HPB

Brazil: ANVISA

Australia: TGA

India: MoH

Bangladesh: Moh

South Korea: KFDA

Japan: PMDA

China: CFDA

Taiwan: DoH